摘要:
Several embodiments of relatively compact transmitter coils and receiver coils having an improved transcutaneous power transfer efficiency. The transmitter coils are preferably applied to the outer surface of a cutaneous layer on a patient's body and held in place using adhesive tape or other appropriate supporting material. Implanted within the patient's body is a receiver coil. To improve the power transfer efficiency of one embodiment, a transmitter coil and receiver coil include cores having pole faces with a substantially larger area than the cross section of the core at other locations. In addition, the core of the receiver coil is substantially shorter than that of the transmitter coil so that the lines of flux produced by the transmitter coil tend to pass through the pole faces of the receiver coil in greater density than they would if the pole faces of the transmitter and receiver cores were spaced identically. Relatively compact configurations for the transmitter core include an angled portion adjacent each of the pole faces so that the main portion of the transmitter core is disposed generally parallel and closely spaced to the surface of the cutaneous layer against which the transmitter core is placed. Further, two separate transmitter windings are provided on the transmitter core with an intermediate section joining the portions of the core on which these windings are disposed. This configuration provides enhanced power transfer capability compared to using a single winding around the intermediate section of the core.
摘要:
A plurality of microminiature light sources (10, 10') are injected at a treatment site to effect photodynamic therapy (PDT). Each of the microminiature light source beads includes an LED chip (12), a rectifier chip (14), and a plurality of electromagnetic receivers (18, 18') encapsulated within a biocompatible, light transmitting material such as silicone, forming a spherical bead that is only a few millimeters in diameter. The light source beads are sufficiently small so that they can be injected into a treatment site such as a tumor (46) from a syringe (58) through a needle (60). A photoreactive agent, which can serve as a carrier fluid for the microminiature light source beads, sensitizes the tissue at the treatment site so that light emitted by the LED chip when energized with an external electromagnetic transmitter (34) kills the tissue or other pathogens at the treatment site that have absorbed the photoreactive agent. Alternatively, a catheter (66) can be used for emplacing the microminiature light source beads at the treatment site.
摘要:
Light developed by an implantable probe is used to illuminate a treatment site that has been perfused with a photoreactive agent. A number of different embodiments of implantable probes are disclosed. Preferably, an array of light emitting diodes (LEDs) or solid-state laser diodes (LDs) are mounted on a light bar inside the implantable probe and are energized either using a storage battery power source, an inductively coupled external transformer, or with current provided in leads running through a flexible catheter that extends outside the patient's body to an external source. The implantable probe is normally intended to be disposed inside a patient's body during a surgical procedure, at a treatment site, and left in place for several days (or longer) after an incision is closed, while light produced by the array of LEDs or solid-state LDs irradiates the treatment site. Alternatively, light from an external light source can be conveyed over one or more optical fibers to an implantable probe that is disposed inside the patient's body to irradiate the treatment site. Waste heat produced by the array of LEDs or LDs disposed on the implantable probe can be employed to augment the PDT by increasing the temperature of the tissue at the treatment site.